Tags

Type your tag names separated by a space and hit enter

The impact of metabolic syndrome on serum total testosterone level in patients with erectile dysfunction.
Aging Male 2014; 17(2):76-80AM

Abstract

OBJECTIVES

To determine the association between metabolic syndrome (MetS) and serum testosterone levels (TT) in patients with erectile dysfunction (ED).

METHODS

This study included 280 ED patients above 40-years-of-age. Participants were divided into two groups according to 2005 criteria of International Diabetes Federation. The severity of ED was determined according to the International Index of Erectile Function-EF (IIEF-EF score; 0-10 severe ED, 11-25 mild to moderate ED). The severity of ED, serum TT levels and other MetS components were compared between the groups.

RESULTS

The mean age of the patients was 55.7 ± 8.2 years. One hundred eighteen patients (%42.1) had MetS. Sixty-eight patients with MetS (57.6%) and 71 patients without MetS (43.8%) had severe ED (p = 0.031). A total of 46 (16.4%) patients had hypogonadism. Hypogonadism was seen more prevalent in patients with MetS (22.9% vs. 11.7%, p = 0.013). Logistic regression analyses for ED risk factors demonstrated that abnormal FBG increased the relative risk of severe ED up to 10.7-fold (p < 0.001) but not presence of hypogonadism (p = 0.706).

CONCLUSION

Metabolic syndrome was seen in almost half of the patients with ED. ED was more severe among MetS patients. Hypogonadism alone is a not risk factor for severe ED.

Authors+Show Affiliations

Department of Urology, Ankara Numune Research and Training Hospital, Ministry of Health , Ankara , Turkey and.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

24576299

Citation

Aslan, Yilmaz, et al. "The Impact of Metabolic Syndrome On Serum Total Testosterone Level in Patients With Erectile Dysfunction." The Aging Male : the Official Journal of the International Society for the Study of the Aging Male, vol. 17, no. 2, 2014, pp. 76-80.
Aslan Y, Guzel O, Balci M, et al. The impact of metabolic syndrome on serum total testosterone level in patients with erectile dysfunction. Aging Male. 2014;17(2):76-80.
Aslan, Y., Guzel, O., Balci, M., Tuncel, A., Yildiz, M., & Atan, A. (2014). The impact of metabolic syndrome on serum total testosterone level in patients with erectile dysfunction. The Aging Male : the Official Journal of the International Society for the Study of the Aging Male, 17(2), pp. 76-80. doi:10.3109/13685538.2014.895318.
Aslan Y, et al. The Impact of Metabolic Syndrome On Serum Total Testosterone Level in Patients With Erectile Dysfunction. Aging Male. 2014;17(2):76-80. PubMed PMID: 24576299.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The impact of metabolic syndrome on serum total testosterone level in patients with erectile dysfunction. AU - Aslan,Yilmaz, AU - Guzel,Ozer, AU - Balci,Melih, AU - Tuncel,Altug, AU - Yildiz,Muslum, AU - Atan,Ali, Y1 - 2014/02/27/ PY - 2014/3/1/entrez PY - 2014/3/1/pubmed PY - 2015/1/13/medline KW - Erectile dysfunction KW - hypogonadism KW - male KW - metabolic syndrome KW - testosterone SP - 76 EP - 80 JF - The aging male : the official journal of the International Society for the Study of the Aging Male JO - Aging Male VL - 17 IS - 2 N2 - OBJECTIVES: To determine the association between metabolic syndrome (MetS) and serum testosterone levels (TT) in patients with erectile dysfunction (ED). METHODS: This study included 280 ED patients above 40-years-of-age. Participants were divided into two groups according to 2005 criteria of International Diabetes Federation. The severity of ED was determined according to the International Index of Erectile Function-EF (IIEF-EF score; 0-10 severe ED, 11-25 mild to moderate ED). The severity of ED, serum TT levels and other MetS components were compared between the groups. RESULTS: The mean age of the patients was 55.7 ± 8.2 years. One hundred eighteen patients (%42.1) had MetS. Sixty-eight patients with MetS (57.6%) and 71 patients without MetS (43.8%) had severe ED (p = 0.031). A total of 46 (16.4%) patients had hypogonadism. Hypogonadism was seen more prevalent in patients with MetS (22.9% vs. 11.7%, p = 0.013). Logistic regression analyses for ED risk factors demonstrated that abnormal FBG increased the relative risk of severe ED up to 10.7-fold (p < 0.001) but not presence of hypogonadism (p = 0.706). CONCLUSION: Metabolic syndrome was seen in almost half of the patients with ED. ED was more severe among MetS patients. Hypogonadism alone is a not risk factor for severe ED. SN - 1473-0790 UR - https://www.unboundmedicine.com/medline/citation/24576299/The_impact_of_metabolic_syndrome_on_serum_total_testosterone_level_in_patients_with_erectile_dysfunction_ L2 - http://www.tandfonline.com/doi/full/10.3109/13685538.2014.895318 DB - PRIME DP - Unbound Medicine ER -